Use of guideline-recommended risk reduction strategies among patients with diabetes and atherosclerotic cardiovascular disease insights from getting to an improved understanding of low-density lipoprotein cholesterol and dyslipidemia management (GOULD)

Suzanne V. Arnold; James A. De Lemos; Robert S. Rosenson; Christie M. Ballantyne; Yuyin Liu; Katherine E. Mues; Shushama Alam; Mary Elliott-Davey; Deepak L. Bhatt; Christopher P. Cannon; Mikhail Kosiborod

doi:10.1161/CIRCULATIONAHA.119.041730

Use of guideline-recommended risk reduction strategies among patients with diabetes and atherosclerotic cardiovascular disease insights from getting to an improved understanding of low-density lipoprotein cholesterol and dyslipidemia management (GOULD)

Suzanne V. Arnold
, James A. De Lemos
, Robert S. Rosenson
, Christie M. Ballantyne
, Yuyin Liu
, Katherine E. Mues
, Shushama Alam
, Mary Elliott-Davey
, Deepak L. Bhatt
, Christopher P. Cannon
, Mikhail Kosiborod

Research output: Contribution to journal › Letter › peer-review

117 Scopus citations

Original language	English
Pages (from-to)	618-620
Number of pages	3
Journal	Circulation
Volume	140
Issue number	7
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.119.041730
State	Published - 13 Aug 2019

Keywords

Coronary artery disease
Diabetes mellitus
Quality of care

Access to Document

10.1161/CIRCULATIONAHA.119.041730

Cite this

Arnold, S. V., De Lemos, J. A., Rosenson, R. S., Ballantyne, C. M., Liu, Y., Mues, K. E., Alam, S., Elliott-Davey, M., Bhatt, D. L., Cannon, C. P., & Kosiborod, M. (2019). Use of guideline-recommended risk reduction strategies among patients with diabetes and atherosclerotic cardiovascular disease insights from getting to an improved understanding of low-density lipoprotein cholesterol and dyslipidemia management (GOULD). Circulation, 140(7), 618-620. https://doi.org/10.1161/CIRCULATIONAHA.119.041730

Arnold, Suzanne V. ; De Lemos, James A. ; Rosenson, Robert S. et al. / Use of guideline-recommended risk reduction strategies among patients with diabetes and atherosclerotic cardiovascular disease insights from getting to an improved understanding of low-density lipoprotein cholesterol and dyslipidemia management (GOULD). In: Circulation. 2019 ; Vol. 140, No. 7. pp. 618-620.

@article{d0ad4332ac6a4b728aba1ee754fa9a28,

title = "Use of guideline-recommended risk reduction strategies among patients with diabetes and atherosclerotic cardiovascular disease insights from getting to an improved understanding of low-density lipoprotein cholesterol and dyslipidemia management (GOULD)",

keywords = "Coronary artery disease, Diabetes mellitus, Quality of care",

author = "Arnold, \{Suzanne V.\} and \{De Lemos\}, \{James A.\} and Rosenson, \{Robert S.\} and Ballantyne, \{Christie M.\} and Yuyin Liu and Mues, \{Katherine E.\} and Shushama Alam and Mary Elliott-Davey and Bhatt, \{Deepak L.\} and Cannon, \{Christopher P.\} and Mikhail Kosiborod",

note = "Funding Information: The GOULD study is funded by Amgen. The coauthors from Amgen reviewed and edited the manuscript for intellectual content; however, the sponsors of the study had no role in the final review and approval of the manuscript for submission.",

year = "2019",

month = aug,

day = "13",

doi = "10.1161/CIRCULATIONAHA.119.041730",

language = "English",

volume = "140",

pages = "618--620",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "7",

}

Arnold, SV, De Lemos, JA, Rosenson, RS, Ballantyne, CM, Liu, Y, Mues, KE, Alam, S, Elliott-Davey, M, Bhatt, DL, Cannon, CP & Kosiborod, M 2019, 'Use of guideline-recommended risk reduction strategies among patients with diabetes and atherosclerotic cardiovascular disease insights from getting to an improved understanding of low-density lipoprotein cholesterol and dyslipidemia management (GOULD)', Circulation, vol. 140, no. 7, pp. 618-620. https://doi.org/10.1161/CIRCULATIONAHA.119.041730

Use of guideline-recommended risk reduction strategies among patients with diabetes and atherosclerotic cardiovascular disease insights from getting to an improved understanding of low-density lipoprotein cholesterol and dyslipidemia management (GOULD). / Arnold, Suzanne V.; De Lemos, James A.; Rosenson, Robert S. et al.
In: Circulation, Vol. 140, No. 7, 13.08.2019, p. 618-620.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Use of guideline-recommended risk reduction strategies among patients with diabetes and atherosclerotic cardiovascular disease insights from getting to an improved understanding of low-density lipoprotein cholesterol and dyslipidemia management (GOULD)

AU - Arnold, Suzanne V.

AU - De Lemos, James A.

AU - Rosenson, Robert S.

AU - Ballantyne, Christie M.

AU - Liu, Yuyin

AU - Mues, Katherine E.

AU - Alam, Shushama

AU - Elliott-Davey, Mary

AU - Bhatt, Deepak L.

AU - Cannon, Christopher P.

AU - Kosiborod, Mikhail

N1 - Funding Information: The GOULD study is funded by Amgen. The coauthors from Amgen reviewed and edited the manuscript for intellectual content; however, the sponsors of the study had no role in the final review and approval of the manuscript for submission.

PY - 2019/8/13

Y1 - 2019/8/13

KW - Coronary artery disease

KW - Diabetes mellitus

KW - Quality of care

UR - https://www.scopus.com/pages/publications/85071353088

U2 - 10.1161/CIRCULATIONAHA.119.041730

DO - 10.1161/CIRCULATIONAHA.119.041730

M3 - Letter

C2 - 31174429

AN - SCOPUS:85071353088

SN - 0009-7322

VL - 140

SP - 618

EP - 620

JO - Circulation

JF - Circulation

IS - 7

ER -

Arnold SV, De Lemos JA, Rosenson RS, Ballantyne CM, Liu Y, Mues KE et al. Use of guideline-recommended risk reduction strategies among patients with diabetes and atherosclerotic cardiovascular disease insights from getting to an improved understanding of low-density lipoprotein cholesterol and dyslipidemia management (GOULD). Circulation. 2019 Aug 13;140(7):618-620. doi: 10.1161/CIRCULATIONAHA.119.041730